A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra
- PMID: 2760616
- DOI: 10.1111/j.1471-4159.1989.tb11759.x
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra
Abstract
The total activity of superoxide dismutase (SOD) and cytosolic and particulate activity of SOD in human substantia nigra and cerebellum were measured by a spectrophotometric method based on the ability of SOD to inhibit the autoxidation of adrenaline. The cytosolic and particulate isoenzymes of SOD were differentiated by the inclusion of potassium cyanide which selectively inhibits cytosolic copper/zinc-dependent SOD activity. In autopsied human brains, there was no difference in total SOD activity, or the activity of SOD in cytosol in substantia nigra of patients dying with Parkinson's disease compared to age-matched controls. However, the activity of the particulate form of SOD was higher in the parkinsonian substantia nigra compared to control tissue. In the cerebellum there was no difference in the total, cytosolic, or particulate activity of SOD between parkinsonian patients and age-matched controls. Increased activity of SOD in particulate fraction may be a protective response to elevated levels of toxic free radicals in the parkinsonian substantia nigra. Alternatively, increased SOD activity may induce cell death through the accumulation of hydrogen peroxide.
Similar articles
-
Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus.J Neurol Sci. 1988 Sep;86(2-3):321-31. doi: 10.1016/0022-510x(88)90108-6. J Neurol Sci. 1988. PMID: 3221244
-
Superoxide dismutase expression in Parkinson's disease.Ann N Y Acad Sci. 1994 Nov 17;738:116-20. doi: 10.1111/j.1749-6632.1994.tb21796.x. Ann N Y Acad Sci. 1994. PMID: 7832421 No abstract available.
-
The paradigm that all oxygen-respiring eukaryotes have cytosolic CuZn-superoxide dismutase and that Mn-superoxide dismutase is localized to the mitochondria does not apply to a large group of marine arthropods.Biochemistry. 1997 Oct 28;36(43):13381-8. doi: 10.1021/bi971052c. Biochemistry. 1997. PMID: 9341231
-
Effects of dopaminergic drugs on superoxide dismutase: implications for senescence.J Neural Transm Suppl. 1993;40:37-45. J Neural Transm Suppl. 1993. PMID: 8294899 Review.
-
[History of deprenyl--the first selective inhibitor of monoamine oxidase type B].Vopr Med Khim. 1997 Nov-Dec;43(6):482-93. Vopr Med Khim. 1997. PMID: 9503565 Review. Russian.
Cited by
-
Magnolol Protects against MPTP/MPP(+)-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson's Disease.Parkinsons Dis. 2012;2012:985157. doi: 10.1155/2012/985157. Epub 2012 May 8. Parkinsons Dis. 2012. PMID: 22655218 Free PMC article.
-
Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.Front Neurosci. 2018 May 23;12:342. doi: 10.3389/fnins.2018.00342. eCollection 2018. Front Neurosci. 2018. PMID: 29875626 Free PMC article. Review.
-
Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells.Neurobiol Dis. 2009 Jun;34(3):487-500. doi: 10.1016/j.nbd.2009.03.004. Epub 2009 Mar 28. Neurobiol Dis. 2009. PMID: 19332121 Free PMC article.
-
Exacerbation of alcohol-induced oxidative stress in rats by polyunsaturated Fatty acids and iron load.Indian J Pharm Sci. 2011 Mar;73(2):152-8. doi: 10.4103/0250-474x.91578. Indian J Pharm Sci. 2011. PMID: 22303057 Free PMC article.
-
The role of β-adrenergic blockers in Parkinson's disease: possible genetic and cell-signaling mechanisms.Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):306-17. doi: 10.1177/1533317513488919. Epub 2013 May 21. Am J Alzheimers Dis Other Demen. 2013. PMID: 23695225 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical